The assessment and management of gamma hydroxybutyrate use in general practice.
Identifieur interne : 000084 ( Main/Exploration ); précédent : 000083; suivant : 000085The assessment and management of gamma hydroxybutyrate use in general practice.
Auteurs : Vicky Phan ; Shalini Arunogiri ; Dan I. LubmanSource :
- Australian journal of general practice [ 2208-7958 ]
Descripteurs français
- KwdFr :
- Adjuvants des anesthésiques (analyse), Adjuvants des anesthésiques (effets indésirables), Humains (MeSH), Mauvais usage des médicaments prescrits (diagnostic), Mauvais usage des médicaments prescrits (thérapie), Médecine générale (méthodes), Médecine générale (tendances), Oxybate de sodium (analyse), Oxybate de sodium (effets indésirables), Troubles liés à une substance (diagnostic), Troubles liés à une substance (psychologie).
- MESH :
- analyse : Adjuvants des anesthésiques, Oxybate de sodium.
- diagnostic : Mauvais usage des médicaments prescrits, Troubles liés à une substance.
- effets indésirables : Adjuvants des anesthésiques, Oxybate de sodium.
- méthodes : Médecine générale.
- psychologie : Troubles liés à une substance.
- tendances : Médecine générale.
- thérapie : Mauvais usage des médicaments prescrits.
- Humains.
English descriptors
- KwdEn :
- Adjuvants, Anesthesia (adverse effects), Adjuvants, Anesthesia (analysis), Drug Overdose (diagnosis), Drug Overdose (therapy), General Practice (methods), General Practice (trends), Humans (MeSH), Sodium Oxybate (adverse effects), Sodium Oxybate (analysis), Substance-Related Disorders (diagnosis), Substance-Related Disorders (psychology).
- MESH :
- chemical , adverse effects : Adjuvants, Anesthesia, Sodium Oxybate.
- chemical , analysis : Adjuvants, Anesthesia, Sodium Oxybate.
- diagnosis : Drug Overdose, Substance-Related Disorders.
- methods : General Practice.
- psychology : Substance-Related Disorders.
- therapy : Drug Overdose.
- trends : General Practice.
- Humans.
Abstract
BACKGROUND
Gamma hydroxybutyrate (GHB) is an illicit drug commonly used in music festival, party and 'chemsex' settings. Most people who use GHB do so occasionally, without dependent use or withdrawal symptoms. However, a minority of users experience harms including unconsciousness and respiratory collapse in overdose. Adverse interactions can also occur when GHB is used with other drugs (eg methamphetamine), necessitating assessment, management or onward referral by general practitioners.
OBJECTIVE
This article describes the use of GHB, with a contemporary update on principles of assessment and management in general practice, brief intervention and harm-minimisation strategies, and indicators for referral to a specialist in dependent use.
DISCUSSION
The assessment and management of individuals with GHB-related harms in general practice is supported by an awareness of the context of use, familiarity with targeted harm-minimisation advice and cognisance of markers of risk indicating onward referral to specialist addiction services when appropriate.
DOI: 10.31128/AJGP-05-19-4953
PubMed: 32008260
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The assessment and management of gamma hydroxybutyrate use in general practice.</title><author><name sortKey="Phan, Vicky" sort="Phan, Vicky" uniqKey="Phan V" first="Vicky" last="Phan">Vicky Phan</name><affiliation><nlm:affiliation>BMed, MPH, MPsychiatry, GCertAlc@DrugSt, Addiction Psychiatry Registrar, Turning Point, Eastern Health, Vic.</nlm:affiliation><wicri:noCountry code="subField">Vic</wicri:noCountry></affiliation></author><author><name sortKey="Arunogiri, Shalini" sort="Arunogiri, Shalini" uniqKey="Arunogiri S" first="Shalini" last="Arunogiri">Shalini Arunogiri</name><affiliation><nlm:affiliation>MBBS (Hons), MSc, MPsychiatry, PhD, FRANZCP, Addiction Psychiatrist and Deputy Clinical Director, Turning Point, Eastern Health, Vic; Senior Lecturer, Monash Addiction Research Centre and Eastern Health Clinical School, Monash University, Vic.</nlm:affiliation><wicri:noCountry code="subField">Vic</wicri:noCountry></affiliation></author><author><name sortKey="Lubman, Dan I" sort="Lubman, Dan I" uniqKey="Lubman D" first="Dan I" last="Lubman">Dan I. Lubman</name><affiliation><nlm:affiliation>BSc (Hons), MBChB, PhD, FRANZCP, FAChAM, Director, Turning Point, Eastern Health, Vic; Professor, Monash Addiction Research Centre and Eastern Health Clinical School, Monash University, Vic.</nlm:affiliation><wicri:noCountry code="subField">Vic</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020 Jan-Feb</date><idno type="RBID">pubmed:32008260</idno><idno type="pmid">32008260</idno><idno type="doi">10.31128/AJGP-05-19-4953</idno><idno type="wicri:Area/Main/Corpus">000330</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000330</idno><idno type="wicri:Area/Main/Curation">000330</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000330</idno><idno type="wicri:Area/Main/Exploration">000330</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The assessment and management of gamma hydroxybutyrate use in general practice.</title><author><name sortKey="Phan, Vicky" sort="Phan, Vicky" uniqKey="Phan V" first="Vicky" last="Phan">Vicky Phan</name><affiliation><nlm:affiliation>BMed, MPH, MPsychiatry, GCertAlc@DrugSt, Addiction Psychiatry Registrar, Turning Point, Eastern Health, Vic.</nlm:affiliation><wicri:noCountry code="subField">Vic</wicri:noCountry></affiliation></author><author><name sortKey="Arunogiri, Shalini" sort="Arunogiri, Shalini" uniqKey="Arunogiri S" first="Shalini" last="Arunogiri">Shalini Arunogiri</name><affiliation><nlm:affiliation>MBBS (Hons), MSc, MPsychiatry, PhD, FRANZCP, Addiction Psychiatrist and Deputy Clinical Director, Turning Point, Eastern Health, Vic; Senior Lecturer, Monash Addiction Research Centre and Eastern Health Clinical School, Monash University, Vic.</nlm:affiliation><wicri:noCountry code="subField">Vic</wicri:noCountry></affiliation></author><author><name sortKey="Lubman, Dan I" sort="Lubman, Dan I" uniqKey="Lubman D" first="Dan I" last="Lubman">Dan I. Lubman</name><affiliation><nlm:affiliation>BSc (Hons), MBChB, PhD, FRANZCP, FAChAM, Director, Turning Point, Eastern Health, Vic; Professor, Monash Addiction Research Centre and Eastern Health Clinical School, Monash University, Vic.</nlm:affiliation><wicri:noCountry code="subField">Vic</wicri:noCountry></affiliation></author></analytic><series><title level="j">Australian journal of general practice</title><idno type="eISSN">2208-7958</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adjuvants, Anesthesia (adverse effects)</term><term>Adjuvants, Anesthesia (analysis)</term><term>Drug Overdose (diagnosis)</term><term>Drug Overdose (therapy)</term><term>General Practice (methods)</term><term>General Practice (trends)</term><term>Humans (MeSH)</term><term>Sodium Oxybate (adverse effects)</term><term>Sodium Oxybate (analysis)</term><term>Substance-Related Disorders (diagnosis)</term><term>Substance-Related Disorders (psychology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adjuvants des anesthésiques (analyse)</term><term>Adjuvants des anesthésiques (effets indésirables)</term><term>Humains (MeSH)</term><term>Mauvais usage des médicaments prescrits (diagnostic)</term><term>Mauvais usage des médicaments prescrits (thérapie)</term><term>Médecine générale (méthodes)</term><term>Médecine générale (tendances)</term><term>Oxybate de sodium (analyse)</term><term>Oxybate de sodium (effets indésirables)</term><term>Troubles liés à une substance (diagnostic)</term><term>Troubles liés à une substance (psychologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Adjuvants, Anesthesia</term><term>Sodium Oxybate</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Adjuvants, Anesthesia</term><term>Sodium Oxybate</term></keywords><keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>Adjuvants des anesthésiques</term><term>Oxybate de sodium</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Drug Overdose</term><term>Substance-Related Disorders</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Mauvais usage des médicaments prescrits</term><term>Troubles liés à une substance</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Adjuvants des anesthésiques</term><term>Oxybate de sodium</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>General Practice</term></keywords><keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Médecine générale</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Troubles liés à une substance</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Substance-Related Disorders</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Médecine générale</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Drug Overdose</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Mauvais usage des médicaments prescrits</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>General Practice</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Gamma hydroxybutyrate (GHB) is an illicit drug commonly used in music festival, party and 'chemsex' settings. Most people who use GHB do so occasionally, without dependent use or withdrawal symptoms. However, a minority of users experience harms including unconsciousness and respiratory collapse in overdose. Adverse interactions can also occur when GHB is used with other drugs (eg methamphetamine), necessitating assessment, management or onward referral by general practitioners.</p></div><div type="abstract" xml:lang="en"><p><b>OBJECTIVE</b></p><p>This article describes the use of GHB, with a contemporary update on principles of assessment and management in general practice, brief intervention and harm-minimisation strategies, and indicators for referral to a specialist in dependent use.</p></div><div type="abstract" xml:lang="en"><p><b>DISCUSSION</b></p><p>The assessment and management of individuals with GHB-related harms in general practice is supported by an awareness of the context of use, familiarity with targeted harm-minimisation advice and cognisance of markers of risk indicating onward referral to specialist addiction services when appropriate.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32008260</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2208-7958</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>1-2</Issue><PubDate><MedlineDate>2020 Jan-Feb</MedlineDate></PubDate></JournalIssue><Title>Australian journal of general practice</Title><ISOAbbreviation>Aust J Gen Pract</ISOAbbreviation></Journal><ArticleTitle>The assessment and management of gamma hydroxybutyrate use in general practice.</ArticleTitle><Pagination><MedlinePgn>73-78</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.31128/AJGP-05-19-4953</ELocationID><Abstract><AbstractText Label="BACKGROUND">Gamma hydroxybutyrate (GHB) is an illicit drug commonly used in music festival, party and 'chemsex' settings. Most people who use GHB do so occasionally, without dependent use or withdrawal symptoms. However, a minority of users experience harms including unconsciousness and respiratory collapse in overdose. Adverse interactions can also occur when GHB is used with other drugs (eg methamphetamine), necessitating assessment, management or onward referral by general practitioners.</AbstractText><AbstractText Label="OBJECTIVE">This article describes the use of GHB, with a contemporary update on principles of assessment and management in general practice, brief intervention and harm-minimisation strategies, and indicators for referral to a specialist in dependent use.</AbstractText><AbstractText Label="DISCUSSION">The assessment and management of individuals with GHB-related harms in general practice is supported by an awareness of the context of use, familiarity with targeted harm-minimisation advice and cognisance of markers of risk indicating onward referral to specialist addiction services when appropriate.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Phan</LastName><ForeName>Vicky</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>BMed, MPH, MPsychiatry, GCertAlc@DrugSt, Addiction Psychiatry Registrar, Turning Point, Eastern Health, Vic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arunogiri</LastName><ForeName>Shalini</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>MBBS (Hons), MSc, MPsychiatry, PhD, FRANZCP, Addiction Psychiatrist and Deputy Clinical Director, Turning Point, Eastern Health, Vic; Senior Lecturer, Monash Addiction Research Centre and Eastern Health Clinical School, Monash University, Vic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lubman</LastName><ForeName>Dan I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>BSc (Hons), MBChB, PhD, FRANZCP, FAChAM, Director, Turning Point, Eastern Health, Vic; Professor, Monash Addiction Research Centre and Eastern Health Clinical School, Monash University, Vic.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Aust J Gen Pract</MedlineTA><NlmUniqueID>101718099</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000759">Adjuvants, Anesthesia</NameOfSubstance></Chemical><Chemical><RegistryNumber>7G33012534</RegistryNumber><NameOfSubstance UI="D012978">Sodium Oxybate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000759" MajorTopicYN="N">Adjuvants, Anesthesia</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062787" MajorTopicYN="N">Drug Overdose</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058006" MajorTopicYN="N">General Practice</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012978" MajorTopicYN="N">Sodium Oxybate</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019966" MajorTopicYN="N">Substance-Related Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32008260</ArticleId><ArticleId IdType="doi">10.31128/AJGP-05-19-4953</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Arunogiri, Shalini" sort="Arunogiri, Shalini" uniqKey="Arunogiri S" first="Shalini" last="Arunogiri">Shalini Arunogiri</name><name sortKey="Lubman, Dan I" sort="Lubman, Dan I" uniqKey="Lubman D" first="Dan I" last="Lubman">Dan I. Lubman</name><name sortKey="Phan, Vicky" sort="Phan, Vicky" uniqKey="Phan V" first="Vicky" last="Phan">Vicky Phan</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SanteMusiqueV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000084 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000084 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SanteMusiqueV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32008260
|texte= The assessment and management of gamma hydroxybutyrate use in general practice.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32008260" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SanteMusiqueV1
| This area was generated with Dilib version V0.6.38. |  |